Everything You Need to Know About the Singulair Mental Health Symptoms

9/6/2022

The drug Singulair is currently the subject of lawsuits from people who say that it made them feel suicidal or that it caused other serious mental health problems. If you or a loved one took Singulair and experienced suicidal ideation or other adverse Singular mental health symptoms, you may be eligible for damages. Please contact a Singulair lawyer today.

Since the introduction of Singulair, there has been rising concern about the possibility of serious mental health issues, including suicidal thoughts and attempts. In March 2020, the FDA began requiring a “black box” warning label on each unit of Singulair, alerting consumers of these dangers. The FDA now advises against using Singulair to treat seasonal or chronic allergies unless no other medications are effective for the patient.

Individuals who took Singulair and suffered suicidal ideation or other Singulair mental health issues might be eligible for compensation. Merck & Co. is currently facing Singulair mental health lawsuits from those who assert that the drug caused them to experience suicidal ideation and other negative Singulair mental health symptoms. Here are four frequently asked questions about the Singulair Mental Health Lawsuits. If you or a loved one took Singulair and experienced suicidal ideation or other adverse Singulair mental health symptoms, you should contact Singulair lawyer Timothy L. Miles. Read on to learn more about the Singulair Mental Health Symptoms and how they were discovered.

Contact Singulair Lawyer Timothy L. Miles today for a free case evaluation

What Are the Singulair Mental Health Symptoms

It has been reported that a wide range of adverse Singulair mental health symptoms have been experienced by Singulair users. These include: Suicidal thoughts, potentially escalating to suicidal ideation and attempted suicide.

If you or a loved one has experienced any of these Singulair mental health symptoms, you may have grounds for a Singulair lawsuit against the drug manufacturer. Contact Singulair lawyer Timothy L. Miles today if you or a loved one has experienced any of these symptoms.

How Were the Singulair Mental Health Symptoms Discovered?

The FDA used data from the Sentinel Initiative to discover neuropsychiatric incidents related to Singulair in addition to animal studies and suicide reports to determine whether to issue new warnings and recommendations. The FDA discovered 82 cases of suicide associated with montelukast. Nineteen cases concerned a patient younger than 17, and 18 cases did not specify the patient's age. A study of mice indicated that montelukast may cross the blood-brain barrier, which would suggest that the drug can enter and harm the brain. The FDA, therefore, decided to upgrade its evaluation of Singulair's mental health risks as a result of all this data.

Contact a Singulair Lawyer today about a Singulair Lawsuit

If you or a loved one are suffering from adverse Singulair mental health symptoms, you may be eligible for compensation. A Singulair Lawyer is standing by ready to review your case for free, and if we take your case, you will not pay anything up front; you won’t pay at all unless we win for you. Call Singulair Lawyer Timothy L. Miles at (855) Tim-MLaw or by submitting this form for a free case evaluation to discuss a Singulair Lawsuit.

Timothy L. Miles, Esq.

T imothy L. Miles is a nationally recognized shareholder rights attorney raised in Nashville, Tennessee. Mr. Miles was recentely selected by Martindale-Hubbell® and ALM as a 2022 Top Ranked Lawyer, 2022 Top Rated Litigator. and a 2022 Elite Lawyer of the South. Mr. Miles also maintains the AV Preeminent Rating by Martindale-Hubbell®, their highest rating for both legal ability and ethics. Mr. Miles is a member of the prestigious Top 100 Civil Plaintiff Trial Lawyers: The National Trial Lawyers Association, a superb rated attorney by Avvo, a recipient of the Lifetime Achievement Award by Premier Lawyers of America (2019) and recognized as a Distinguished Lawyer, Recognizing Excellence in Securities Law, by Lawyers of Distinction (2019). Mr. Miles has published over sixty articles on various issues of the law, including class actions, whistleblower cases, products liability, and more.

Categories